122 related articles for article (PubMed ID: 26219108)
41. [A Case of Descending Colon Adenocarcinoma with Neuroendocrine Differentiation Successfully Treated with FOLFIRI plus Bevacizumab].
Kakuta S; Takayama W; Kou T; Satou M; Sugaya M
Gan To Kagaku Ryoho; 2016 Jan; 43(1):129-32. PubMed ID: 26809541
[TBL] [Abstract][Full Text] [Related]
42. Pancreatic metastasis from colon carcinoma treated with radiotherapy with palliative benefit.
Saif MW; Kaley K
JOP; 2010 Nov; 11(6):644-5; author reply 650. PubMed ID: 21068505
[No Abstract] [Full Text] [Related]
43. Chemoembolization in Conjunction with Bevacizumab: Preliminary Results.
Fiorentini G; Sarti D; Aliberti C; Carandina R; Mulazzani L; Felicioli A; Guadagni S
J Vasc Interv Radiol; 2018 Sep; 29(9):1236-1239. PubMed ID: 30146190
[TBL] [Abstract][Full Text] [Related]
44. [A case of metastatic lung and liver tumors from rectal cancer treated with oral UFT and CPT-11 by hepatic arterial infusion followed by FOLFOX and FOLFIRI].
Hoshikawa K; Aoki K; Noda H; Oyama K; Nitta H; Wakabayashi G
Gan To Kagaku Ryoho; 2008 Nov; 35(11):1965-7. PubMed ID: 19011353
[TBL] [Abstract][Full Text] [Related]
45. Primary Adenocarcinoma with Focal Choriocarcinomatous Differentiation in the Sigmoid Colon.
Oh SK; Kim HW; Kang DH; Choi CW; Choi YY; Lim HK; Goo JJ; Choi SY
Korean J Gastroenterol; 2015 Nov; 66(5):291-6. PubMed ID: 26586354
[TBL] [Abstract][Full Text] [Related]
46. NCCN guideline updates: colon and rectal cancers, version 1.2004.
National Comprehensive Cancer Network
J Natl Compr Canc Netw; 2004 Jul; 2(4):284-5. PubMed ID: 19795595
[No Abstract] [Full Text] [Related]
47. Rectal cancer clinical practice guidelines in oncology.
Engstrom PF; Benson AB; Chen YJ; Choti MA; Dilawari RA; Enke CA; Fakih MG; Fuchs C; Kiel K; Knol JA; Leong LA; Ludwig KA; Martin EW; Rao S; Saif MW; Saltz L; Skibber JM; Venook AP; Yeatman TJ;
J Natl Compr Canc Netw; 2005 Jul; 3(4):492-508. PubMed ID: 16038640
[No Abstract] [Full Text] [Related]
48. [An elderly case of recurrent colon cancer responding to weekly S-1 chemotherapy leading to partial response].
Arita A; Sakai Y; Fujimoto M; Mochizuki K
Gan To Kagaku Ryoho; 2008 Jan; 35(1):141-3. PubMed ID: 18195545
[TBL] [Abstract][Full Text] [Related]
49. Minidose warfarin is associated with a high incidence of International Normalized Ratio elevation during chemotherapy with FOLFOX regimen.
Magagnoli M; Masci G; Carnaghi C; Zucali PA; Castagna L; Morenghi E; Santoro A
Ann Oncol; 2003 Jun; 14(6):959-60. PubMed ID: 12796035
[No Abstract] [Full Text] [Related]
50. [Two cases of unstable angina in patients treated with bevacizumab].
Okada Y; Okura Y; Takii Y
Gan To Kagaku Ryoho; 2010 Jul; 37(7):1405-8. PubMed ID: 20647738
[TBL] [Abstract][Full Text] [Related]
51. Triplet Chemotherapy (FOLFOXIRI) Plus Bevacizumab Versus Doublet Chemotherapy (FOLFOX/FOLFIRI) Plus Bevacizumab in Conversion Therapy for Metastatic Colorectal Cancer: a Meta-Analysis.
Shui L; Wu YS; Lin H; Shui P; Sun Q; Chen X
Cell Physiol Biochem; 2018; 48(5):1870-1881. PubMed ID: 30092572
[TBL] [Abstract][Full Text] [Related]
52. Correlation between response to chemotherapy with concomitant bevacizumab for hepatic metastasis of colorectal cancer and degree of enhancement using contrast-enhanced computed tomography.
Osawa G; Yoshimatsu K; Yokomizo H; Okayama S; Sagawa M; Naritaka Y
Cancer Chemother Pharmacol; 2013 Jul; 72(1):209-15. PubMed ID: 23670642
[TBL] [Abstract][Full Text] [Related]
53. [A case of liver metastasis of rectal cancer, refractory to previous chemotherapy(5-FU/LV, irinotecan, oxaliplatin) responding to bevacizumab combined with FOLFIRI chemotherapy].
Nishigami K; Kawami H; Yamaguchi T; Yamaguchi K; Kato S
Gan To Kagaku Ryoho; 2009 Oct; 36(10):1765-8. PubMed ID: 19838045
[TBL] [Abstract][Full Text] [Related]
54. Complete Response to Aflibercept-FOLFIRI in One Patient With Colorectal Cancer Refractory to Bevacizumab-FOLFOX: A Possible Autocrine Vascular Endothelial Growth Factor Receptor 2-Related Mechanism.
Kim S; Cayre A; Jary M; Jacquin M; Arbez-Gindre F; Fein F; Lakkis Z; Nguyen T; Borg C
Clin Colorectal Cancer; 2016 Dec; 15(4):e229-e234. PubMed ID: 27600470
[No Abstract] [Full Text] [Related]
55. [A case of high CEA colon cancer responding to neoadjuvant chemotherapy with FOLFIRI].
Nakajima S; Sonoda K; Kadokawa Y; Kawabe A; Yamamoto T; Egawa H
Gan To Kagaku Ryoho; 2010 Oct; 37(10):1995-8. PubMed ID: 20948272
[TBL] [Abstract][Full Text] [Related]
56. [Efficacy and safety of antivascular drugs after anti-EFGR: aflibercept after cetuximab, a clinical case].
Aroldi F; Zaniboni A
Recenti Prog Med; 2015 Dec; 106(12):653e-6e. PubMed ID: 26780078
[TBL] [Abstract][Full Text] [Related]
57. FOLFIRI+bevacizumab induction chemotherapy followed by bevacizumab or observation in metastatic colorectal cancer, a phase III trial (PRODIGE 9--FFCD 0802).
Aparicio T; Linot B; Le Malicot K; Bouché O; Boige V; François E; Ghiringhelli F; Legoux JL; Ben Abdelghani M; Phelip JM; Faroux R; Dahan L; Taieb J; Bedenne L
Dig Liver Dis; 2015 Apr; 47(4):271-2. PubMed ID: 25677925
[No Abstract] [Full Text] [Related]
58. [Clinical significance of a transient increase in carcinoembryonic antigen and carbohydrate antigen 19-9 in patients with metastatic colorectal cancer receiving chemotherapy].
Li YH; An X; Xiang XJ; Wang ZQ; Wang FH; Feng F; Jiang WQ; He YJ; Xu RH
Ai Zheng; 2009 Sep; 28(9):939-44. PubMed ID: 19728911
[TBL] [Abstract][Full Text] [Related]
59. [A case of metastatic colon carcinoma in which a continuous intrahepatic artery-infusion of 5-FU leucovorin and cisplatin, and systemic chemotherapy with CPT-11 was very effective].
Ishikawa T; Nakamura M; Ohkuma K; Hisano C; Nakano S; Maruyama T; Kaji Y; Niho Y; Masumoto N
Gan To Kagaku Ryoho; 2000 Aug; 27(9):1443-7. PubMed ID: 10969604
[TBL] [Abstract][Full Text] [Related]
60. [A recurrence after surgery for colon cancer with metastases of the liver and periaortic lymph nodes, with CR achieved by using bevacizumab+mFOLFOX6].
Matsukawa S; Shiratori T; Kugimiya M; Matsuo S; Kaji S; Aoyama Y
Gan To Kagaku Ryoho; 2010 Jul; 37(7):1389-91. PubMed ID: 20647734
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
